Esophageal Cancer
Copyright ©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. Apr 28, 2005; 11(16): 2385-2389
Published online Apr 28, 2005. doi: 10.3748/wjg.v11.i16.2385
Table 2 Association analysis of the MMP1 SNP with the risk of ESCC and GCA development.
1G/1G2G/2G2G/1G+2G/2GaOR (95%CI)3aOR (95%CI)4
Overall
Normal51 (14.9)194 (55.4)299 (85.4)
ESCC28 (12.0)130 (55.6)206 (88.0)1.28 (0.78-2.09)1.23 (0.38-2.05)
GCA20 (10.9)112 (61.2)163 (89.1)1.39 (0.80-2.41)1.34 (0.74-2.40)
Non-smoker1
Normal25 (15.6)89 (55.6)135 (84.4)
ESCC10 (10.6)58 (61.7)84 (89.4)1.55 (0.65-3.46)1.54 (0.68-3.48)
GCA10 (13.5)40 (54.1)64 (86.5)1.12 (0.49-2.58)1.20 (0.38-3.82)
Smoker
Normal18 (15.0)64 (53.3)102 (85.0)
ESCC14 (14.6)46 (47.9)82 (85.4)1.03 (0.48-2.19)0.93 (0.42-2.06)
GCA8 ( 8.7)59 (64.1)84 (91.3)1.80 (0.74-4.37)1.36 (0.46-4.05)
Negative family history2
ESCC16 (12.5)73 (57.0)112 (87.5)1.19 (0.65-2.18)1.18 (0.63-2.20)
GCA7 ( 7.3)54 (56.2)89 (92.7)1.19 (0.56-2.51)0.42 (0.16-1.04)
Positive family history3
ESCC8 (14.3)29 (51.8)48 (85.7)1.02 (0.46-2.29)0.95 (0.41-2.21)
GCA10 (16.1)38 (61.3)52 (83.9)0.95 (0.59-1.53)0.72 (0.31-1.70)